Literature DB >> 2737231

Use of dimethicone to reduce the fall in gastric potential difference induced by bile salts.

J F Bergmann1, G Simoneau, G Chantelair, C Caulin, J M Segrestaa.   

Abstract

The gastric potential difference (PD) was measured in ten healthy volunteers after sodium taurocholate intake. This bile salt was given after treatment with dimethicone or placebo in a cross-over design study. With dimethicone the fall in PD was lower (16.1 vs. 24.8 mV,) and shorter (32.5 vs. 51.0 min) than with the placebo. Our result suggests that the silicone can prevent the formation of the gastric lesions induced by bile salts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2737231     DOI: 10.1007/bf00558299

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.

Authors:  D Y Graham; N M Agrawal; S H Roth
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

2.  Gastric mucosal damage by taurine and glycine conjugates of chenodeoxycholic acid.

Authors:  R B Black; F F Naylor; N S Stenhouse
Journal:  Am J Dig Dis       Date:  1977-12

3.  Persistent gastric-protective effect of antacid evaluated by measurement of transmucosal gastric potential difference.

Authors:  J F Bergmann; C Caulin; G Simoneau; G Dorf; J M Segrestaa
Journal:  Clin Pharmacol Ther       Date:  1988-11       Impact factor: 6.875

4.  Profile of gastric potential difference in man. Effects of aspirin, alcohol, bile, and endogenous acid.

Authors:  M G Geall; S F Phillips; W H Summerskill
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

5.  Bile acids, the "barrier," and reflux-related clinical disorders of the gastric mucosa.

Authors:  W P Ritchie
Journal:  Surgery       Date:  1977-08       Impact factor: 3.982

6.  [Effect of smectite on the changes in gastric potential difference induced by aspirin in man].

Authors:  R Dahan; B Schatz; J P Isal; C Caulin
Journal:  Gastroenterol Clin Biol       Date:  1984-11

7.  Gastric potential difference as a model in clinical pharmacology: assessment of gastric mucosal response to aspirin.

Authors:  H Laule; P W Lücker; P Altmayer; M A Eldon
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  [Antacids and gastric mucosa. Protective effect of an antacid on acetylsalicylic acid induced functional lesions in the human gastric mucosa].

Authors:  W F Caspary; H Kausch
Journal:  Fortschr Med       Date:  1977-08-18

9.  Prevention by mild irritants of gastric necrosis produced in rats by sodium taurocholate.

Authors:  T K Chaudhury; A Robert
Journal:  Dig Dis Sci       Date:  1980-11       Impact factor: 3.199

10.  Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins.

Authors:  A Robert; J E Nezamis; C Lancaster; J P Davis; S O Field; A J Hanchar
Journal:  Am J Physiol       Date:  1983-07
View more
  2 in total

1.  What is the better formulation of microencapsulated potassium chloride?

Authors:  G Simoneau; J F Bergmann; R Pamphile; C Caulin; J M Segrestaa
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

2.  Efficacy of Curcuma longa in treatment of postprandial distress syndrome: An open-label randomized-controlled trial.

Authors:  Nicharat Sawangroj; Jiratha Budkaew; Bandit Chumworathayi
Journal:  F1000Res       Date:  2019-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.